Summaries of scientific recommendations on classification of advanced therapy medicinal products: update

7 janvier 2019

BlueRegWatch

The European Medicines Agency's Committee for Advanced Therapies (CAT) delivers scientific recommendations on whether a medicine can be classified as an advanced therapy medicinal product (ATMP). The Agency publishes the outcomes of these assessments in the format of summary reports.

BlueRegWatch

Vous avez aimé cet article ? Partagez le sur les réseaux sociaux :

Découvrez notre dernier livre blanc

En savoir plus